Page last updated: 2024-08-21

alpha-aminopyridine and Neoplastic Processes

alpha-aminopyridine has been researched along with Neoplastic Processes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chao, YS; Chen, CN; Chen, JS; Chou, CH; Chu, SH; Wu, YH; Yang, MH1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Neoplastic Processes

ArticleYear
CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor.
    Scientific reports, 2022, 01-20, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Aminopyridines; Animals; Antibodies, Monoclonal; Benzamides; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Therapy, Combination; Immune Checkpoint Inhibitors; Interferon-gamma; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid-Derived Suppressor Cells; Neoplasm Invasiveness; Neoplastic Processes; Programmed Cell Death 1 Receptor; Tumor Microenvironment; Xenograft Model Antitumor Assays

2022